Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $13.2100 (0%) ($13.1800 - $13.4700) on Sat. Jul. 15, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.33% (three month average) | RSI | 24 | Latest Price | $13.2100(0%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.2% a day on average for past five trading days. | Weekly Trend | HALO declines -3.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting HALO price | HALO will decline at least -1.165% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.165% (StdDev 2.33%) | Hourly BBV | 0 () | Intraday Trend | -0.2% | | | |
|
Resistance Level | $13.54 | 5 Day Moving Average | $13.07(1.07%) | 10 Day Moving Average | $13.02(1.46%) | 20 Day Moving Average | $13.54(-2.44%) | To recent high | -11.3% | To recent low | 11.9% | Market Cap | $N/A | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |